Introducing the 2023 Bioanalysis special-themed issue on laboratory structure and management for nonregulated bioanalysis

BioanalysisVol. 15, No. 3 ForewordIntroducing the 2023 Bioanalysis special-themed issue on laboratory structure and management for nonregulated bioanalysisQin C Ji & Gary J JenkinsQin C Ji*Author for correspondence: E-mail Address: qin.ji@abbvie.comAbbVie, 1 North Waukegan Road, North Chicago, IL 60064, USASearch for more papers by this author & Gary J Jenkins**Author for correspondence: E-mail Address: gary.jenkins@abbvie.comAbbVie, 1 North Waukegan Road, North Chicago, IL 60064, USASearch for more papers by this authorPublished Online:30 Mar 2023https://doi.org/10.4155/bio-2023-0037AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleReferences1. Weng N, Ji QC. Preface to the 2014 special focus issue of Bioanalysis on bioanalytical laboratory structure and management. Bioanalysis 6(10), 1275–1277 (2014).Link, Google Scholar2. Wang Y-T, Maes E, Heinle L et al. Integrity and efficiency: AbbVie's journey of building an integrated non-regulated bioanalytical laboratory. Bioanalysis 15(3), (2023).Google Scholar3. Sarvaiya H, Niu S, Ladror D et al. Bioanalytical strategy for the characterization and bioanalysis of biologics – a global non-regulated BA lab perspective. Bioanalysis 15(3), (2023).Google Scholar4. Summerfield SG, Tang H, Decman V, Abberley L, Gunn G, Yang E. GSK bioanalytical hub model in bioanalysis: maximising the synergies of co-locating various platforms in support of regulated and non-regulated study endpoints. Bioanalysis 15(3), (2023).Google Scholar5. Santiago BG, Eisennagel SH, Peckham GE et al. Perspective on high-throughput bioanalysis to support in vitro assays in early drug discovery. Bioanalysis 15(3), (2023).Google Scholar6. Bruenner BA, Pham RV, Rufai W, James CA. Perspectives on a flexible strategy for the management of non-regulated bioanalysis. Bioanalysis 15(3), (2023).Google Scholar7. Fu Y, Li W, Picard F. Non-regulated LC–MS/MS bioanalysis in support of early drug development: a Novartis perspective. Bioanalysis 15(3), (2023).Google Scholar8. Liu A, Wang K, Sun D et al. Using innovative tools for in vitro ADME studies to efficiently and effectively support drug development. Bioanalysis 15(3), (2023).Google ScholarFiguresReferencesRelatedDetails Vol. 15, No. 3 STAY CONNECTED Metrics Downloaded 118 times History Received 3 March 2023 Accepted 3 March 2023 Published online 30 March 2023 Published in print February 2023 Information© 2023 Newlands PressFinancial & competing interests disclosureBoth authors are employees of AbbVie and may own AbbVie stock. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download